Perivascular adipose tissue as a regulator of vascular disease pathogenesis: identifying novel therapeutic targets

Br J Pharmacol. 2017 Oct;174(20):3411-3424. doi: 10.1111/bph.13666. Epub 2016 Dec 14.

Abstract

Adipose tissue (AT) is an active endocrine organ with the ability to dynamically secrete a wide range of adipocytokines. Importantly, its secretory profile is altered in various cardiovascular disease states. AT surrounding vessels, or perivascular AT (PVAT), is recognized in particular as an important local regulator of vascular function and dysfunction. Specifically, PVAT has the ability to sense vascular paracrine signals and respond by secreting a variety of vasoactive adipocytokines. Due to the crucial role of PVAT in regulating many aspects of vascular biology, it may constitute a novel therapeutic target for the prevention and treatment of vascular disease pathogenesis. Signalling pathways in PVAT, such as those using adiponectin, H2 S, glucagon-like peptide 1 or pro-inflammatory cytokines, are among the potential novel pharmacological therapeutic targets of PVAT.

Linked articles: This article is part of a themed section on Molecular Mechanisms Regulating Perivascular Adipose Tissue - Potential Pharmacological Targets? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.20/issuetoc.

Publication types

  • Review

MeSH terms

  • Adipose Tissue / physiology*
  • Animals
  • Blood Vessels / physiology*
  • Humans
  • Metabolic Diseases / physiopathology
  • Vascular Diseases / drug therapy*
  • Vascular Diseases / physiopathology